The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|4|6|693-702

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.4, Iss.6, 2004-01, pp. : 693-702

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Specific Inhibitors of CYP707A, a Key Enzyme in the Catabolism of Abscisic Acid

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3230-3244

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis and Metastasis Inhibitors for the Treatment of Malignant Melanoma

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 649-661

Bentham Science Publishers

Access to resources Recommend Favorite

ETS transcription factors and targets in tumour invasion, angiogenesis and bone metastasis

By Seth A.   Catzavelos C.   Vary C.   Ascione R.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 87-107

Informa Healthcare

Access to resources Recommend Favorite

Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 3, 2002-12 ,pp. : 167-175

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Click-Chemistry in the Development of Peptidomimetic Enzyme Inhibitors

By  

Current Medicinal Chemistry, Vol. 21, Iss. 13, 2014-04 ,pp. : 1467-1477

Bentham Science Publishers

Access to resources Recommend Favorite